Article

Robert Gamble Discusses Patient-Centered Medical Homes Option for Cancer Patients

Mr. Robert “Bo” Gamble, Director, Strategic Practice Initiatives, Community Oncology Alliance in Washington, DC, addresses how the ACO model isn’t a good fit for cancer care because of unpredictability and the high cost of oncology medications.

Mr. Gamble also discusses the standards set by the NCQA and why he thinks they are on target with coordination, outreach, and patient satisfaction, but that the value component is missing for cancer care.

Related Videos
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill
Dr Margrit Wiesendanger
Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia
Michael Goulet, DO, pulmonary and critical care fellow, Temple University Hospital
Eboni Price-Haywood, MD, and Toni Flowers, PhD
Tom Belmon, CAP, GPBCH
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Tom Belmont
Pieter Sonneveld, MD, PhD
Related Content
Future validation studies with a larger sample size are warranted to ensure the technique will be useful in a clinical setting. | Image credit: Artur Wnorowski - stock.adobe.com
May 18th 2025

Novel, Non-Invasive Skin Cancer Detection Method Shows Promise

Jared Kaltwasser
The tool could make it easier for clinicians to rule out melanoma without the need for excision.
managed care cast logo
May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS
Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
While CTCs were identified regardless of disease stage, the current study identified large variations in the presence of CTCs between nonmetastatic and metastatic disease | Image Credit: Innovative Creation - stock.adobe.com
May 14th 2025

Flow Cytometry Can Reliably Identify CTC in Melanoma

AJMC Contributor
The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a significant positive correlation between the number of CTCs and the stage of disease.
Managed Care Cast
May 9th 2025

Frameworks for Advancing Health Equity: Food as Medicine

Giuliana Grossi Colleen Ereditario, MPH, RD, LDN
Learn about how Allegheny Health Network's "Food as Medicine" initiative tackles food insecurity and enhances health through personalized nutrition support.
At 3 months, hospitalizations among patients enrolled in RSM were 19% lower vs historical controls. | Image Credit: Nuttapong punna - stock.adobe.com
May 14th 2025

Remote Symptom Monitoring Linked to Reduced Hospitalization Risk for Patients With Cancer

Rose McNulty
Remote symptom monitoring in cancer care reduces hospitalizations, enhances value-based care, and supports diverse patient populations, according to new findings.
Offline data augmentation can significantly enhance deep learning techniques, improving classification performance compared to models trained solely on original clinician skin images. | Image Credit: Alexander - stock.adobe.com
May 12th 2025

Optimized Deep Learning Model Classifies Smartphone Images of Malignant Skin Lesions

AJMC Contributor
Across various classes, the researchers identified a model that, when coupled with appropriate data augmentation and optimization partner, may help aid in the detection of skin cancer.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo